WILLIAM QUINN: Open Payments
NPI 1861277964 · CORINTH, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$540 in 28 payments from 3 companies in 2025. Trend: 2023 $312 · 2024 $828 · 2025 $540
Food & beverage: $540
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $212 |
| Novo Nordisk Inc | 8 | $208 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $120 |
Products named: VRAYLAR, Wegovy, Kerendia, Ozempic, QULIPTA, Rybelsus.
Industry payments across MS — which companies pay providers there.
